# FDA Inspection 1251631 - Sanghadiya Rakesh Nareshbhai, M.D. - October 10, 2024

Source: https://www.keypedia.com/records/fda_inspections/sanghadiya-rakesh-nareshbhai-md/d3e08f18-4e5c-471f-9068-628708f3782c
Source feed: FDA_Inspections

> FDA Inspection 1251631 for Sanghadiya Rakesh Nareshbhai, M.D. on October 10, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251631
- Company Name: Sanghadiya Rakesh Nareshbhai, M.D.
- Inspection Date: 2024-10-10
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1251631 - 2024-10-10](https://www.keypedia.com/records/fda_inspections/sanghadiya-rakesh-nareshbhai-md/f2f8652c-5a30-4321-9026-c883759cc58a)

Company: https://www.keypedia.com/companies/sanghadiya-rakesh-nareshbhai-md/781b3f2a-cb5c-4827-a02d-502daf2349a2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c